Keynote: Signals & Shocks: How Today's Economic and Policy Climate Is Reshaping Pharma and Biotech Strategy

Session details:

Geopolitical tensions, shifting tariffs, inflation volatility, and sweeping drug pricing reforms - all these forces are reshaping how pharma and biotech companies plan for the future. This session delivers a clear, nonpartisan look at what’s unfolding across Washington, global markets, and the broader economy, helping leaders across the life sciences understand where the biggest risks and opportunities lie. 

• We will breakdown how U.S. and global economic signals, including tariffs, inflation, and capital markets, are influencing investment and portfolio decisions
  
  
• Better understand the downstream effects of White House and Congressional drug pricing policies, including the IRA and future legislation
  
  
• Explore how global trade and supply chain disruptions are affecting cost structure, site selection, and long-term margin pressure
  
  
• Take a look at how executives across functions (commercial, R&D, finance) are building flexible strategies for unpredictable environments